Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study

SIMPLE SUMMARY: Up to 50% of myocarditis events developed in cancer patients upon treatment with immune checkpoint inhibitors (ICIs) are fatal. Therefore, identification of clinical risk factors predicting myocarditis onset during treatment with ICIs is important for the purpose of cardiac surveilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Noseda, Roberta, Ruinelli, Lorenzo, van der Gaag, Linda C., Ceschi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700285/
https://www.ncbi.nlm.nih.gov/pubmed/33238481
http://dx.doi.org/10.3390/cancers12113480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700285/
https://www.ncbi.nlm.nih.gov/pubmed/33238481
http://dx.doi.org/10.3390/cancers12113480

Ejemplares similares